전신성염증반응증후군 환자에서 급성기반응물질로서 호중구 젤라틴분해효소 연관 리포칼린의 의의
Significance of Neutrophil Gelatinase-Associated Lipocalin Level as an Acute-Phase Reactant in Patients with Systemic Inflammatory Response Syndrome
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
배경: 본 연구는 염증성질환 환자에서 급성기반응물질과 혈청크레아티닌(serum creatinine, sCr) 상승에 대한 지표로서 혈장 호중구젤라틴분해효소연관리포칼린(neutrophil gelatinase-associated lipocalin, NGAL) 농도의 의의에 대하여 조사하였다. 방법: 전체 63명의 전신성염증반응증후군(systemic inflammatory response syndrome, SIRS)환자와 149명의 non-SIRS환자를 조사하였다. 혈장 NGAL (plasma NGAL, pNGAL) 농도는 형광면역법으로 분석하였다. sCr은 72시간 동안 매일 측정하였고 sCr농도의 상승 여부를 조사하였다. 고감도 C-반응성단백(high-sensitivity C-reactive protein, hsCRP)은 라텍스비탁법을 이용하여 분석하였다. 결과: SIRS 환자에서 pNGAL의 중앙값은 154 ng/mL였는데, non-SIRS 환자군의 86 ng/mL과 정상대조군의 62 ng/mL보다 각각 유의하게 높았다(P<0.001). SIRS 진단을 위한 pNGAL과 hsCRP의 ROC곡선 아래 면적(area under the ROC curve, AUC)은 각각 0.725 (95% CI, 0.664-0.781)와 0.749 (95% CI, 0.685-0.809)였고, 두 지표 간 AUC에 유의한 차이는 없었다(P=0.375). 다변량 회귀분석에서 pNGAL의 대수값은 hsCRP (β=0.546. P<0.001)와 혈청알부민/sCr 비(serum albumin/sCr ratio, sACR) (β=-0.351, P<0.001)와 유의한 연관성이 있었다. SIRS군에서 48-72시간 동안, 양의 delta sCr에 대한 pNGAL의 AUC는 0.649 (95% CI, 0.542-0.746, P=0.023)였다. 결론: pNGAL은 전신성염증질환 여부를 판단하는 데 hsCRP에 비교될 정도의 민감도를 보이는 염증관련인자로 생각된다. pNGAL을 측정함으로써 전신성염증반응증후군 환자에서 48-72시간 동안 sCr 상승 가능성에 대한 추가적인 정보를 얻을 수 있을 것이다.
Abstract
Background: We investigated the significance of plasma neutrophil gelatinase-associated lipocalin (pNGAL) level as an acute-phase reactant and an index for an increase in serum creatinine (sCr) level in patients with inflammatory diseases. Methods: A total of 63 patients with systemic inflammatory response syndrome (SIRS) and 149 without SIRS were evaluated, and pNGAL level was determined using a fluorescence immunoassay. sCr levels were measured daily during three days, and the difference between the initial and follow-up sCr levels was defined as a delta sCr value. Serum albumin/sCr ratio (sACR) was calculated. High-sensitivity C-reactive protein (hsCRP) level was determined using a latex turbidometric method. Results: The median pNGAL level in the SIRS group (154 ng/mL) was significantly higher than that in the non-SIRS (86 ng/mL) and control (62 ng/mL) groups (P<0.001, respectively). The area under the ROC curve (AUC) of pNGAL for diagnosing SIRS was 0.725 (95% CI, 0.664-0.781), which was not significantly different from that of hsCRP (0.749; 95% CI, 0.685-0.809; P=0.375). Multivariate regression analyses revealed that log-pNGAL was significantly associated with hsCRP (β=0.546, P<0.001) and sACR (β=0.351, P<0.001). The AUC of pNGAL for the positive delta sCr in 48-72 hr was 0.649 (95% CI, 0.542-0.746, P=0.023) in the SIRS group. Conclusions: pNGAL is comparable to hsCRP as an inflammation-related parameter, and its measurement may provide additional information for a potential increase in sCr during 48-72 hr in patients with SIRS.
참고문헌 (27)
- Flower DR, "Structure and sequence relationships in the lipocalins and related proteins", Protein Sci, 2, pp.753~761 (1993)
- Flo TH, "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
- Clifton MC, "Siderocalins : siderophore-binding proteins of the innate immune system", Biometals, 22, pp.557~564 (2009)
- Borregaard N, "Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein", Biometals, 19, pp.211~215 (2006)
- Schmidt-Ott KM, "Dual action of neutrophil gelatinase-associated lipocalin", J Am Soc Nephrol, 18, pp.407~413 (2007)
- Dent CL, "Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study", Crit Care, 11, pp.R127~ (2007)
- Clerico A, "Neutrophil gelatinase-associated lipocalin(NGAL)as biomarker of acute kidney injury : a review of the laboratory characteristics and clinical evidences", Clin Chem Lab Med, 50, pp.1505~1517 (2012)
- Wu J, "Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes", Exp Ther Med, 6, pp.1482~1488 (2013)
- Bolignano D, "Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients", Kidney Blood Press Res, 32, pp.91~98 (2009)
- Sahinarslan A, "Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease", Coron Artery Dis, 22, pp.333~338 (2011)
- Bagshaw SM, "Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness", Intensive Care Med, 36, pp.452~461 (2010)
- Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.1992, 101[DOI]
- Haase M, "NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis", Am J Kidney Dis, 54, pp.1012~1024 (2009)
- Kim H, "Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis", Clin Biochem, 46, pp.1414~1418 (2013)
- Kim SS, "Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients", Diabetes Res Clin Pract, 97, pp.251~257 (2012)
- Martensson J, "Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury", Intensive Care Med, 36, pp.1333~1340 (2010)
- Fujino RS, "Spermatogonial cell-mediated activation of an IkappaBzeta-independent nuclear factor-kappaB pathway in Sertoli cells induces transcription of the lipocalin-2 gene", Mol Endocrinol, 20, pp.904~915 (2006)
- Xue JL, "Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001", J Am Soc Nephrol, 17, pp.1135~1142 (2006)
- Clec’h C, "Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis", Crit Care, 15, pp.R128~ (2011)
- Moran SM, "Course of acute renal failure studied by a model of creatinine kinetics", Kidney Int, 27, pp.928~937 (1985)
- Al-Ismaili Z, "Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application", Pediatr Nephrol, 26, pp.29~40 (2011)
- Devarajan P, "Neutrophil gelatinase-associated lipocalin(NGAL) : a new marker of kidney disease", Scand J Clin Lab Invest Suppl, 241, pp.89~94 (2008)
- Ronco C, "Subclinical AKI is still AKI", Crit Care, 21(16), pp.313~ (2012)
- Wang Y, "Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans", Clin Chem, 5(3), pp.34~41 (2007)
- Xu SY, "Serum measurements of human neutrophil lipocalin(HNL)discriminate between acute bacterial and viral infections", Scand J Clin Lab Invest, 55, pp.125~131 (1995)
- Bachorzewska-Gajewska H, "Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography", Nephrol Dial Transplant, 22, pp.295~296 (2007)
- Fjaertoft G, "Human neutrophil lipocalin(HNL)as a diagnostic tool in children with acute infections : a study of the kinetics", Acta Paediatr, 94, pp.661~666 (2005)
